Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 65 Records) |
Query Trace: Breast Neoplasms and MLH1[original query] |
---|
High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer. Scientific reports 2019 Jul 9 (1): 10966. Lee Seung Eun, Lee Hye Seung, Kim Kyoung-Yeon, Park Jung-Hoon, Roh Hanseong, Park Ha Young, Kim Wan-Se |
Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer. World journal of clinical oncology 2019 Nov 10 (11): 358-368. Manchana Tarinee, Phowthongkum Prasit, Teerapakpinyo Chinacho |
Correlation of MLH1 polymorphisms, survival statistics, in silico assessment and gene downregulation with clinical outcomes among breast cancer cases. Molecular biology reports 2019 Nov . Malik Saima Shakil, Zia Ayisha, Mubarik Sumaira, Masood Nosheen, Rashid Sajid, Sherrard Alice, Khan Muhammad Bilal, Khadim Muhammad Tah |
A Pediatric Case of Glioblastoma Multiforme Associated With a Novel Germline p.His112CysfsTer9 Mutation in the MLH1 Gene Accompanied by a p.Arg283Cys Mutation in the TP53 Gene: A Case Report. Frontiers in genetics 2019 11 10 952. Stajkovska Aleksandra, Mehandziska Sanja, Rosalia Rodney, Stavrevska Margarita, Janevska Marija, Markovska Martina, Kungulovski Ivan, Mitrev Zan, Kungulovski Gor |
Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy. Genes 2019 10 10 (10): . Urbina-Jara Laura Keren, Rojas-Martinez Augusto, Martinez-Ledesma Emmanuel, Aguilar Dione, Villarreal-Garza Cynthia, Ortiz-Lopez Roc |
Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls. International journal of cancer 2020 Jul . Akcay Izzet Mehmet, Celik Elifnaz, Agaoglu Nihat Bugra, Alkurt Gizem, Kizilboga Akgun Tugba, Yildiz Jale, Enc Feruze, Kir Gozde, Canbek Sezin, Kilic Ali, Zemheri Ebru, Ezberci Fikret, Ozcelik Melike, Dinler Doganay Gizem, Doganay Leve |
Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants. Frontiers in oncology 2020 6 10 666. Nikitin Aleksey G, Chudakova Daria A, Enikeev Rafael F, Sakaeva Dina, Druzhkov Maxim, Shigapova Leyla H, Brovkina Olga I, Shagimardanova Elena I, Gusev Oleg A, Gordiev Marat |
Investigating the Link between Lynch Syndrome and Breast Cancer. European journal of breast health 2020 4 16 (2): 106-109. Sheehan Megan, Heald Brandie, Yanda Courtney, Kelly Erinn Downs, Grobmyer Stephen, Eng Charis, Kalady Matthew, Pederson Hol |
Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC medical genomics 2021 7 14 (1): 185. Winham Stacey J, Wang Chen, Heinzen Ethan P, Bhagwate Aditya, Liu Yuanhang, McDonough Samantha J, Stallings-Mann Melody L, Frost Marlene H, Vierkant Robert A, Denison Lori A, Carter Jodi M, Sherman Mark E, Radisky Derek C, Degnim Amy C, Cunningham Julie |
Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer. Human mutation 2021 7 42 (10): 1265-1278. Johnatty Sharon E, Pesaran Tina, Dolinsky Jill, Yussuf Amal, LaDuca Holly, James Paul A, O'Mara Tracy A, Spurdle Amanda |
Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients. Oncotarget 2021 Mar 12 (7): 686-697. Barakeh Duna H, Aljelaify Rasha, Bashawri Yara, Almutairi Amal, Alqubaishi Fatimah, Alnamnakani Mohammed, Almubarak Latifa, Al Naeem Abdulrahman, Almushawah Fatema, Alrashed May, Abedalthagafi Mal |
Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in genetics 2021 12 12 674094. Su Yifan, Yao Qianlan, Xu Yuyin, Yu Chengli, Zhang Jing, Wang Qian, Li Jiwei, Shi Di, Yu Baohua, Zeng Yupeng, Zhu Xiaoli, Bai Qianming, Zhou Xiaoy |
[Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 10 43 (10): 1088-1093. Tang X J, Yang M Y, Zhu L Z, Xu D, Yuan |
Liquid Biopsy as a Diagnostic and Prognostic Tool for Women and Female Dogs with Breast Cancer. Cancers 2021 Oct 13 (20): . Colombo Jucimara, Moschetta-Pinheiro Marina Gobbe, Novais Adriana Alonso, Stoppe Bruna Ribeiro, Bonini Enrico Dumbra, Gonçalves Francine Moraes, Fukumasu Heidge, Coutinho Luiz Lehmann, Chuffa Luiz Gustavo de Almeida, Zuccari Debora Aparecida Pires de Camp |
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 10 28 (2): 404-413. Schwartz Christopher J, da Silva Edaise M, Marra Antonio, Gazzo Andrea M, Selenica Pier, Rai Vikas K, Mandelker Diana, Pareja Fresia, Misyura Maksym, D'Alfonso Timothy M, Brogi Edi, Drullinsky Pamela, Razavi Pedram, Robson Mark E, Drago Joshua Z, Wen Hannah Y, Zhang Liying, Weigelt Britta, Shia Jinru, Reis-Filho Jorge S, Zhang Ho |
Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes. JNCI cancer spectrum 2021 1 5 (1): . Kurian Allison W, Ward Kevin C, Abrahamse Paul, Hamilton Ann S, Katz Steven |
Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. Asian Pacific journal of cancer prevention : APJCP 2022 6 23 (6): 2027-2033. Gervas Polina, Molokov Aleksey, Babyshkina Nataliya, Kiselev Artem, Zarubin Aleksei, Yumov Evgeny, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. JCO precision oncology 2022 2 1 1-12. Kurian Allison W, Hughes Elisha, Handorf Elizabeth A, Gutin Alexander, Allen Brian, Hartman Anne-Renee, Hall Michael |
Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer. Journal of Cancer 2022 2 13 (3): 869-876. Park Song Ee, Kim Hee Sung, Jung Eun-Jung, Suh Ja Hee, Min Hyeyoung, Chi Kyong-Choun, Kim Jong Won, Park Joong-Min, Hwang In G |
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders. Journal of medical genetics 2022 11 . Carrasco Estela, López-Fernández Adrià, Codina-Sola Marta, Valenzuela Irene, Cueto-González A M, Villacampa Guillermo, Navarro Victor, Torres-Esquius Sara, Palau Dolors, Cruellas Mara, Torres Maite, Perez-Dueñas Belen, Abulí Anna, Diez Orland, Sábado-Álvarez Constantino, García-Arumí Elena, Tizzano Eduardo F, Moreno Lucas, Balmaña Judi |
The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021. Frontiers in genetics 2022 11 13 1020543. Roht Laura, Tooming Mikk, Rekker Kadri, Roomere Hanno, Toome Kadri, Murumets Ülle, Šamarina Ustina, Õunap Katrin, Kahre Tii |
No Evidence of Increased Risk of Breast Cancer in Women With Lynch Syndrome Identified by Multigene Panel Testing. JCO precision oncology 2022 1 4 51-60. Stoll Jessica, Rosenthal Eric, Cummings Shelly, Willmott Jamie, Bernhisel Ryan, Kupfer Sonia |
Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling. Mutation research 2023 7 827 111831. Zeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzo?lu, Mutlu Do?an, Öztürk Ate?, Ece Esin, ?rem Bilgetekin, Umut Demirci, Ça?lar Köseo?lu, Alper Topal, Nuri Karadurmu?, Haktan Ba??? Erdem, Taha Bah |
Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. JAMA oncology 2023 5 . Xuan Chen, Margaret A Meyer, Jennifer L Kemppainen, Masayasu Horibe, Shruti Chandra, Shounak Majumder, Gloria M Petersen, Kari G Ra |
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy. Human genomics 2023 5 17 (1): 43. Nermine H Zakaria, Doaa Hashad, Marwa H Saied, Neamat Hegazy, Alyaa Elkayal, Eman Tay |
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Frontiers in genetics 2023 2 14 1094260. Díaz-Velásquez Clara Estela, Gitler Rina, Antoniano Adriana, Kershenovich Sefchovich Ronny, De La Cruz-Montoya Aldo Hugo, Martínez-Gregorio Héctor, Rojas-Jiménez Ernesto Arturo, Cortez Cardoso Penha Ricardo, Terrazas Luis Ignacio, Wegman-Ostrosky Talia, Levi-Lahad Ephrat, Zabaleta Jovanny, Perdomo Sandra, Vaca-Paniagua Feli |
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 2023 2 4 (2): 156-163. Mian Abrar, Wei Jun, Shi Zhuqing, Rifkin Andrew S, Zheng S Lilly, Glaser Alexander P, Kearns James T, Helfand Brian T, Xu Jianfe |
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human genomics 2023 1 17 (1): 2. Kim Jinyong, Jeong Kyeonghun, Jun Hyeji, Kim Kwangsoo, Bae Jeong Mo, Song Myung Geun, Yi Hanbaek, Park Songyi, Woo Go-Un, Lee Dae-Won, Kim Tae-Yong, Lee Kyung-Hun, Im Seock- |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: